Graft-versus-host disease therapy: something else beyond glucocorticoids?
作者信息
Martínez Carmen, Urbano-Ispízua Alvaro
出版信息
Haematologica. 2011 Sep;96(9):1249-51. doi: 10.3324/haematol.2011.050534.
Abstract
摘要
相似文献
1
Graft-versus-host disease therapy: something else beyond glucocorticoids?
Haematologica. 2011 Sep;96(9):1249-51. doi: 10.3324/haematol.2011.050534.
2
Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids.西罗莫司在没有全身糖皮质激素的急性移植物抗宿主病的一线治疗中显示出活性。
Haematologica. 2011 Sep;96(9):1351-6. doi: 10.3324/haematol.2011.041236. Epub 2011 May 12.
3
Sirolimus immunosuppression for graft-versus-host disease prophylaxis and therapy: an update.西罗莫司免疫抑制治疗移植物抗宿主病的预防和治疗：更新。
Curr Opin Hematol. 2010 Nov;17(6):500-4. doi: 10.1097/MOH.0b013e32833e5b2e.
4
Nodular regenerative hyperplasia causing portal hypertension in a patient with chronic graft versus host disease: response to sirolimus.
Acta Haematol. 2014;132(1):49-52. doi: 10.1159/000356736. Epub 2014 Jan 15.
5
Preface. Sirolimus and kidney transplantation.
Nefrologia. 2006;26 Suppl 2:1-2.
6
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease.西罗莫司联合他克莫司和皮质类固醇用于治疗难治性慢性移植物抗宿主病。
Br J Haematol. 2005 Aug;130(3):409-17. doi: 10.1111/j.1365-2141.2005.05616.x.
7
Rapamycin for Kaposi's sarcoma and graft-versus-host disease in bone marrow transplant recipient.雷帕霉素用于骨髓移植受者的卡波西肉瘤和移植物抗宿主病
Transplantation. 2010 Mar 15;89(5):633-4. doi: 10.1097/TP.0b013e3181c892c3.
8
Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease.西罗莫司（雷帕霉素）用于治疗类固醇难治性急性移植物抗宿主病。
Transplantation. 2001 Dec 27;72(12):1924-9. doi: 10.1097/00007890-200112270-00010.
9
Sirolimus for solid organ transplantation in children.西罗莫司用于儿童实体器官移植
Pediatr Transplant. 2005 Jun;9(3):269-76. doi: 10.1111/j.1399-3046.2005.00305.x.
10
Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus.使用mTOR抑制剂依维莫司治疗激素难治性慢性移植物抗宿主病患者的生活质量改善情况。
Clin Transplant. 2014 Dec;28(12):1410-5. doi: 10.1111/ctr.12472. Epub 2014 Nov 3.
引用本文的文献
1
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study.芦可替尼治疗激素耐药性慢性移植物抗宿主病：REACH3 研究的日本亚组分析。
Int J Hematol. 2024 Dec;120(6):705-716. doi: 10.1007/s12185-024-03850-9. Epub 2024 Oct 3.
2
Resolution of Inflammation in Acute Graft-Versus-Host-Disease: Advances and Perspectives.急性移植物抗宿主病炎症的消退：进展与展望。
Biomolecules. 2022 Jan 5;12(1):75. doi: 10.3390/biom12010075.
3
Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cells.人类不变自然杀伤 T 细胞通过优先诱导常规树突状细胞凋亡促进耐受。
Haematologica. 2022 Feb 1;107(2):427-436. doi: 10.3324/haematol.2020.267583.
4
Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host Disease.可溶性DNAX辅助分子-1作为急性移植物抗宿主病的预测生物标志物
PLoS One. 2016 Jun 3;11(6):e0154173. doi: 10.1371/journal.pone.0154173. eCollection 2016.
5
Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10.间质基质细胞输注通过增加产生白细胞介素 10 的 CD5+ 调节性 B 细胞改善难治性慢性移植物抗宿主病。
Leukemia. 2015 Mar;29(3):636-46. doi: 10.1038/leu.2014.225. Epub 2014 Jul 18.
6
Gamma irradiation preserves immunosuppressive potential and inhibits clonogenic capacity of human bone marrow-derived mesenchymal stromal cells.γ射线照射可保留人骨髓间充质基质细胞的免疫抑制潜能并抑制其克隆形成能力。
J Cell Mol Med. 2014 Jun;18(6):1184-93. doi: 10.1111/jcmm.12264. Epub 2014 Mar 21.
本文引用的文献
1
Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids.西罗莫司在没有全身糖皮质激素的急性移植物抗宿主病的一线治疗中显示出活性。
Haematologica. 2011 Sep;96(9):1351-6. doi: 10.3324/haematol.2011.041236. Epub 2011 May 12.
2
The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study.利妥昔单抗敏感的慢性移植物抗宿主病的免疫表型：一项 II 期研究。
Haematologica. 2011 Sep;96(9):1380-4. doi: 10.3324/haematol.2011.041814. Epub 2011 May 5.
3
The kaleidoscope of glucorticoid effects on immune system.糖皮质激素对免疫系统影响的万花筒。
Autoimmun Rev. 2011 Apr;10(6):305-10. doi: 10.1016/j.autrev.2010.11.009. Epub 2011 Jan 9.
4
Reduced mortality after allogeneic hematopoietic-cell transplantation.异基因造血细胞移植后的死亡率降低。
N Engl J Med. 2010 Nov 25;363(22):2091-101. doi: 10.1056/NEJMoa1004383.
5
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.慢性移植物抗宿主病临床实践共识会议：慢性移植物抗宿主病二线治疗。
Biol Blood Marrow Transplant. 2011 Jan;17(1):1-17. doi: 10.1016/j.bbmt.2010.05.011. Epub 2010 May 26.
6
Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.慢性移植物抗宿主病（GVHD）临床实践共识会议：慢性 GVHD 的一线和局部治疗。
Biol Blood Marrow Transplant. 2010 Dec;16(12):1611-28. doi: 10.1016/j.bbmt.2010.06.015. Epub 2010 Jun 25.
7
Acute graft-versus-host disease: from the bench to the bedside.急性移植物抗宿主病：从 bench 到 bedside
Blood. 2009 Nov 12;114(20):4327-36. doi: 10.1182/blood-2009-06-204669. Epub 2009 Aug 27.
8
Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis.利妥昔单抗在类固醇难治性慢性移植物抗宿主病中的疗效：一项系统评价和荟萃分析。
Biol Blood Marrow Transplant. 2009 Sep;15(9):1005-13. doi: 10.1016/j.bbmt.2009.04.003. Epub 2009 Jun 10.
9
Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network.依那西普、霉酚酸酯、地尼白介素或喷司他丁联合皮质类固醇治疗急性移植物抗宿主病：血液与骨髓移植临床试验网络的一项随机2期试验
Blood. 2009 Jul 16;114(3):511-7. doi: 10.1182/blood-2009-03-212290. Epub 2009 May 14.
10
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.人类慢性移植物抗宿主病中B细胞稳态改变与BAFF过量
Blood. 2009 Apr 16;113(16):3865-74. doi: 10.1182/blood-2008-09-177840. Epub 2009 Jan 23.
Zotero 插件